Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity
- PMID: 12909720
- PMCID: PMC187891
- DOI: 10.1073/pnas.1633803100
Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity
Abstract
There are many sources of genetic diversity, ranging from programmed mutagenesis in antibody genes to random mutagenesis during species evolution or development of cancer. We propose that mutations in DNA sequence-specific transcription factors that _target response elements (REs) in many genes can also provide for rapid and broad phenotypic diversity, if the mutations lead to altered binding affinities at individual REs. To test this concept, we examined the in vivo transactivation capacity of wild-type human and murine p53 and 25 partial function mutants. The p53s were expressed in yeast from a rheostatable promoter, and the transactivation capacities toward >15 promoter REs upstream of a reporter gene were measured. Surprisingly, there was wide variation in transactivation by the mutant p53s toward the various REs. This is the first study to address directly the impact of mutations in a sequence-specific transcription factor on transactivation from a wide array of REs. We propose a master gene hypothesis for phenotypic diversity where the master gene is a single transcriptional activator (or repressor) that regulates many genes through different REs. Mutations of the master gene can lead to a variety of simultaneous changes in both the selection of _targets and the extent of transcriptional modulation at the individual _targets, resulting in a vast number of potential phenotypes that can be created with minimal mutational changes without altering existing protein-protein interactions.
Figures
Similar articles
-
Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.Oncogene. 2001 Jun 7;20(26):3409-19. doi: 10.1038/sj.onc.1204457. Oncogene. 2001. PMID: 11423991
-
Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter _target sequence.Mol Cell Biol. 2002 Dec;22(24):8612-25. doi: 10.1128/MCB.22.24.8612-8625.2002. Mol Cell Biol. 2002. PMID: 12446780 Free PMC article.
-
Noncanonical DNA motifs as transactivation _targets by wild type and mutant p53.PLoS Genet. 2008 Jun 27;4(6):e1000104. doi: 10.1371/journal.pgen.1000104. PLoS Genet. 2008. PMID: 18714371 Free PMC article.
-
Potentiating the p53 network.Discov Med. 2010 Jul;10(50):94-100. Discov Med. 2010. PMID: 20670604 Review.
-
Functional diversity in the gene network controlled by the master regulator p53 in humans.Cell Cycle. 2005 Aug;4(8):1026-9. doi: 10.4161/cc.4.8.1904. Epub 2005 Aug 7. Cell Cycle. 2005. PMID: 16082206 Review.
Cited by
-
von Willebrand factor type D domain mutant of SVS-1/SUSD2, vWD(m), induces apoptosis in HeLa cells.Cancer Sci. 2007 Jun;98(6):909-15. doi: 10.1111/j.1349-7006.2007.00467.x. Epub 2007 Apr 12. Cancer Sci. 2007. PMID: 17428257 Free PMC article.
-
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 _target sequences.Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1500-5. doi: 10.1073/pnas.0909129107. Epub 2010 Jan 4. Proc Natl Acad Sci U S A. 2010. PMID: 20080630 Free PMC article.
-
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.Mol Cancer Res. 2011 Mar;9(3):271-9. doi: 10.1158/1541-7786.MCR-10-0496. Epub 2011 Feb 22. Mol Cancer Res. 2011. PMID: 21343334 Free PMC article.
-
Mutant p53K120R expression enables a partial capacity to modulate metabolism.Front Genet. 2022 Sep 26;13:974662. doi: 10.3389/fgene.2022.974662. eCollection 2022. Front Genet. 2022. PMID: 36226181 Free PMC article.
-
Regression based predictor for p53 transactivation.BMC Bioinformatics. 2009 Jul 14;10:215. doi: 10.1186/1471-2105-10-215. BMC Bioinformatics. 2009. PMID: 19602281 Free PMC article.
References
-
- Gearhart, P. J. (2002) Nature 419, 29–31. - PubMed
-
- Hanahan, D. & Weinberg, R. A. (2000) Cell 100, 57–70. - PubMed
-
- Lucht, J. M., Mauch-Mani, B., Steiner, H. Y., Metraux, J. P., Ryals, J. & Hohn, B. (2002) Nat. Genet. 30, 311–314. - PubMed
-
- Giraud, A., Radman, M., Matic, I. & Taddei, F. (2001) Curr. Opin. Microbiol. 4, 582–585. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous